| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Clinical and Molecular Hepatology Search > Browse Articles > Search



Unmet need in chronic hepatitis B management
Lilian Yan Liang, Grace Lai-Hung Wong
Clin Mol Hepatol.2019;25(2):172-180.   Published online February 12, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0106
                                 Cited By 2
Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
Chung-Feng Huang, Ming-Lung Yu
Clin Mol Hepatol.2019;25(2):168-171.   Published online February 11, 2019     
DOI: https://doi.org/10.3350/cmh.2018.1014
                              
Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization
Kittipitch Bannangkoon, Keerati Hongsakul, Teeravut Tubtawee, Teerha Piratvisuth
Clin Mol Hepatol.2019;25(1):74-85.   Published online February 28, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0072
                              
Radiomics and radiogenomics of primary liver cancers
Woo Kyoung Jeong, Neema Jamshidi, Ely Richard Felker, Steven Satish Raman, David Shinkuo Lu
Clin Mol Hepatol.2019;25(1):21-29.   Published online November 16, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1007
                                 Cited By 4
Complete cure of advanced hepatocellular carcinoma with right adrenal gland metastasis and portal vein thrombosis by multiple applications of an interdisciplinary therapy: case report with 8-year follow up
Hojung Jung, Byung Ik Kim, Yong Kyun Cho, Woo Kyu Jeon, Hong Joo Kim, Hyun Pyo Hong
Clin Mol Hepatol.2018;24(4):424-429.   Published online November 14, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0032
                              
Severe acute alcoholic hepatitis and liver transplant: A never-ending mournful story
Aiman Obed, Abdalla Bashir, Steffen Stern, Anwar Jarrad
Clin Mol Hepatol.2018;24(4):358-366.   Published online October 24, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0044
                              
Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion
Danbi Lee, Han Chu Lee, Jihyun An, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee
Clin Mol Hepatol.2018;24(2):144-150.   Published online January 16, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0041
                                 Cited By 2
Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion
Jin Wook Chung
Clin Mol Hepatol.2018;24(2):135-136.   Published online February 22, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1001
                              
Strategic application of radiotherapy for hepatocellular carcinoma
Seo Hee Choi, Jinsil Seong
Clin Mol Hepatol.2018;24(2):114-134.   Published online February 14, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0073
                                 Cited By 5
Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend
Grace Lai-Hung Wong
Clin Mol Hepatol.2018;24(2):108-113.   Published online January 22, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0068
                                 Cited By 6
Epidemiology of liver cancer in South Korea
Bo Hyun Kim, Joong-Won Park
Clin Mol Hepatol.2018;24(1):1-9.   Published online December 18, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0112
                                 Cited By 23
Complete response of advanced hepatocellular carcinoma to sorafenib : another case and a comprehensive review
Tae Suk Kim, Ji Hoon Kim, Baek hui Kim, Young-Sun Lee, Yang Jae Yoo, Seong Hee Kang, Sang-June Suh, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun
Clin Mol Hepatol.2017;23(4):340-346.   Published online June 20, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0070
                                 Cited By 3
Treatment options after sorafenib failure in patients with hepatocellular carcinoma
Imane El Dika, Ghassan K. Abou-Alfa
Clin Mol Hepatol.2017;23(4):273-279.   Published online November 20, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0108
                                 Cited By 7
Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma
Edward Wolfgang Lee, Sarah Khan
Clin Mol Hepatol.2017;23(4):265-272.   Published online November 8, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0111
                                 Cited By 11
Surveillance of hepatocellular carcinoma: is only ultrasound enough?
Woo Kyoung Jeong
Clin Mol Hepatol.2017;23(3):222-223.   Published online September 19, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0046
                                 Cited By 1
Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B
Won Sohn, Ju-Yeon Cho, Ji Hoon Kim, Jung Il Lee, Hyung Joon Kim, Min-Ah Woo, Sin-Ho Jung, Yong-Han Paik
Clin Mol Hepatol.2017;23(2):170-178.   Published online May 16, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0086
                              Supplementary         Cited By 5
Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion
Jihyun An, Kwang Sun Lee, Kang Mo Kim, Do Hyun Park, Sang Soo Lee, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee
Clin Mol Hepatol.2017;23(2):160-169.   Published online May 16, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0088
                                 Cited By 3
Meta-analysis of the correlation between the rs17401966 polymorphism in kinesin family member 1B and susceptibility to hepatitis B virus related hepatocellular carcinoma
Mingkuan Su, Jianfeng Guo, Jiancheng Huang
Clin Mol Hepatol.2017;23(2):138-146.   Published online April 21, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0083
                                 Cited By 2
Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
Do Young Kim
Clin Mol Hepatol.2017;23(2):123-124.   Published online June 23, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0107
                              
Radioembolization for the treatment of hepatocellular carcinoma
Hyo-Cheol Kim
Clin Mol Hepatol.2017;23(2):109-114.   Published online May 10, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0004
                                 Cited By 12
Aggressive tumor recurrence after radiofrequency ablation for hepatocellular carcinoma
Tae Wook Kang, Hyo Keun Lim, Dong Ik Cha
Clin Mol Hepatol.2017;23(1):95-101.   Published online March 24, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0006
                                 Cited By 6
Is scheduled second chemoembolization necessary for early stage hepatocellular carcinoma showing complete response after first chemoembolization?
Jin Wook Chung
Clin Mol Hepatol.2017;23(1):31-33.   Published online March 16, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0102
                                 Cited By 1
Percutaneous cryoablation for hepatocellular carcinoma
Kyoung Doo Song
Clin Mol Hepatol.2016;22(4):509-515.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0079
                                 Cited By 10
Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma
Ju-Yeon Cho, Moon Seok Choi, Gil Sun Lee, Won Sohn, Jemma Ahn, Dong-Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Clin Mol Hepatol.2016;22(4):477-486.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0048
                                 Cited By 7
Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization
Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon, Seung Min Jung, Bohyun Jang, Jong Young Choi
Clin Mol Hepatol.2016;22(4):458-465.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0054
                                 Cited By 2
Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma
Lauren M. Ladd, Temel Tirkes, Mark Tann, David M. Agarwal, Matthew S. Johnson, Bilal Tahir, Kumaresan Sandrasegaran
Clin Mol Hepatol.2016;22(4):450-457.   Published online December 14, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0036
                                 Cited By 3
Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis
Yejoo Jeon, Eun Sun Jang, Yun Suk Choi, Jin-Wook Kim, Sook-Hyang Jeong
Clin Mol Hepatol.2016;22(3):359-365.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0033
                                 Cited By 3
Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B
Jaemin Lee, Sun Hong Yoo, Won Sohn, Hyung Woo Kim, Yong Sun Choi, Jung Ho Won, Jin Young Heo, Sang Jong Park, Young Min Park
Clin Mol Hepatol.2016;22(3):339-349.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0021
                                 Cited By 3
Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?
Byoung Kuk Jang
Clin Mol Hepatol.2016;22(3):336-338.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0104
                              
The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
Ioannis Varbobitis, George V. Papatheodoridis
Clin Mol Hepatol.2016;22(3):319-326.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0045
                                 Cited By 24
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
The Liver Week 2019
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.         
COUNTER
TODAY : 257
TOTAL : 214129